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ABSTRACT The heartworm Dirofilaria immitis is an
important parasite of dogs. Transmitted by mosquitoes
in warmer climatic zones, it is spreading across south-
ern Europe and the Americas at an alarming pace.
There is no vaccine, and chemotherapy is prone to
complications. To learn more about this parasite, we
have sequenced the genomes of D. immitis and its
endosymbiont Wolbachia. We predict 10,179 protein
coding genes in the 84.2 Mb of the nuclear genome,
and 823 genes in the 0.9-Mb Wolbachia genome. The D.
immitis genome harbors neither DNA transposons nor
active retrotransposons, and there is very little genetic
variation between two sequenced isolates from Europe
and the United States. The differential presence of
anabolic pathways such as heme and nucleotide biosyn-
thesis hints at the intricate metabolic interrelationship
between the heartworm and Wolbachia. Comparing the
proteome of D. immitis with other nematodes and with
mammalian hosts, we identify families of potential drug
targets, immune modulators, and vaccine candidates.
This genome sequence will support the development of
new tools against dirofilariasis and aid efforts to com-
bat related human pathogens, the causative agents of
lymphatic filariasis and river blindness.—Godel, C.,
Kumar, S., Koutsovoulos, G., Ludin, P., Nilsson, D.,
Comandatore, F., Wrobel, N., Thompson, M., Schmid,
C. D., Goto, S., Bringaud, F., Wolstenholme, A., Bandi,
C., Epe, C., Kaminsky, R., Blaxter, M., Mäser, P. The
genome of the heartworm, Dirofilaria immitis, reveals drug
and vaccine targets. FASEB J. 26, 4650–4661 (2012).
www.fasebj.org
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The heartworm DIROFILARIA IMMITIS (Leidy, 1856) is a
parasitic nematode of mammals. The definitive host is
the dog; however, it also infects cats, foxes, coyotes,
and, very rarely, humans (1). Dirofilariasis of dogs is a
severe and potentially fatal disease. Adult nematodes of
20 to 30 cm reside in the pulmonary arteries, and the
initial damage is to the lung. The spectrum of subse-
quent pathologies related to chronic heartworm infec-
tion is broad, the most serious manifestation being
heart failure. Recent rapid spread of D. immitis through
the United States and southern Europe (2, 3) is being
favored by multiple factors. Global warming is expand-
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ing the activity season of vector mosquitoes, increasing
their abundance and the likelihood of transmission of
the parasite, and there are growing numbers of pets,
reservoir animals, and “traveling” dogs (2, 3).
D. immitis is an onchocercid filarial nematode, related
to important parasites of humans, such as Onchocerca
volvulus, the agent of river blindness. The D. immitis
lifecycle is typical for Onchocercidae. Microfilariae, shed
into the bloodstream by adult females, are ingested by a
mosquito (various species, including Aedes, Anopheles, and
Culex spp.) where they develop into third-stage larvae (L3)
and migrate to the labium. Feeding by an infected mos-
quito introduces L3 into the skin. The prepatent period
in the newly bitten dog is 6–9 mo, during which the
injected larvae undergo two further molts and migrate via
muscle fibers to the pulmonary vasculature, where the
adult nematodes develop. At present, diagnosis is effective
only for patent infections, because it is based on detection
of circulating microfilariae or antigens from mature fe-
males. Treatment of dirofilariasis is also problematic,
because the arsenical melarsomine dihydrochloride, the
only adulticide approved by the U.S. Food and Drug
Administration, can cause adverse neurological reactions.
Treatment carries a significant risk of lethality due to block-
age of the pulmonary artery by dead nematodes. No vaccine
is available. These issues, together with the alarming increas-
ing spread ofD. immitis, prompted the American Heartworm
Society to recommend year-round chemoprophylactic treat-
ment of dogs (4) to kill the larval stages before they develop
into adults. This requires monthly administration of anthel-
mintics, predominantly macrocyclic lactones, such as iver-
mectin, milbemycin, or moxidectin.
Human-infective parasites related to D. immitis cause
subcutaneous filariasis and river blindness and are
endemic in tropical and subtropical regions around the
globe, with an estimated 380 million people affected
(5). Improved diagnostics, new drugs, and, ultimately,
effective vaccines are sorely needed. The sequencing of
the Brugia malayi genome provides a platform for
rational drug design, but by itself this single sequence
cannot distinguish between idiosyncratic and shared
targets that could be exploited for control (6).
Most of the filarial nematodes that cause diseases in
humans and animals, including D. immitis, O. volvulus,
Wuchereria bancrofti, and B. malayi, have been shown to
harbor intracellular symbiotic bacteria of the genus Wolba-
chia (e.g., refs. 7–10). These bacteria are vertically trans-
mitted to the nematode progeny, via transovarial trans-
mission. In most of the infected nematode species, all
individuals are infected (reviewed in ref. 11). Even
though the exact role of Wolbachia in filarial biology has
not yet been determined, these bacteria are thought to be
beneficial to the nematode host. Indeed, antibiotics that
target Wolbachia have been shown to have deleterious
effects on filarial nematodes, blocking reproduction, in-
ducing developmental arrest, and killing adult nematodes
(e.g., refs. 7–9). This has led to development of research
projects with the aim of developing anti-Wolbachia chemo-
therapy as a novel strategy for the control of filarial
diseases. Wolbachia has also been implicated in the immuno-
pathogenesis of filarial diseases, with a role in the develop-
ment of pathological outcomes, such as inflammation and
clouding of the cornea that is typical of river blindness (12).
The genome of Wolbachia is thus an additional source of
potential drug targets (7–10), but a single genome cannot
reveal shared vs. unique biochemical weaknesses.
The human pathogenic Onchocercidae do not rep-
resent an attractive market for the pharmacological
industry, because projected incomes from impover-
ished communities in developing endemic nations
would be unlikely to cover the costs of drug develop-
ment. The heartworm may hold a possible solution to
this problem, because the market potential for novel
canine anthelmintics is big, given the costs for heart-
worm prevention of $75–100/dog/yr and the estimated
number of 80 million dogs in the United States (13).
Choosing drug targets that are likely to be conserved in
related, human pathogenic species may benefit both
canine and human medicine. Here we present the draft
genome sequences of D. immitis and its Wolbachia endo-
symbiont (wDi) and use these data to investigate the
relationship between nematode and endosymbiont and
identify new drug and vaccine targets.
MATERIALS AND METHODS
D. immitis isolates and DNA sequencing
We sequenced two canine D. immitis isolates, one from Pavia,
Italy, and the other from Athens, Georgia, USA. The Pavia
isolate was established in a laboratory lifecycle after primary
isolation from an infected dog. Adult Pavia nematodes used
for DNA extraction were recovered after necropsy of dogs
infected as a control group in ongoing investigations (permit
FR401e/08 from the Veterinary Office Canton de Fribourg,
Switzerland). The Athens nematodes used for DNA and RNA
extraction were from a naturally infected dog necropsied as
part of routine clinical surveillance and were not from an
established strain. Genomic DNA was extracted (QIAamp
DNA extraction kit; Qiagen, Valencia, CA, USA) from indi-
vidual adult female nematodes from Pavia and Athens iso-
lates, and RNA was extracted (RNeasy kit; Qiagen) from
individual female and male nematodes from Athens. Whole-
genome shotgun sequences were generated at The GenePool
Genomics Facility (University of Edinburgh, Edinburgh, UK)
and at Fasteris SA (Geneva, Switzerland) using Illumina
GAIIx and HiSeq2000 instruments (Illumina, Inc., San Diego,
CA, USA). Several short insert (100- to 400-bp) paired-end
amplicon libraries and long insert (3- to 4-kb) mate-pair
amplicon libraries were made, and data from four of these
were used in the final assembly (details are given on the Web
site http://www.dirofilaria.org). These yielded a raw data
total of 28 Gb in 295 million reads [European Bioinformatics
Institute (EBI) Short Read Archive, accession number
ERA032353; http://www.ebi.ac.uk/ena/]. After trimming
low-quality bases (Phred score 20) and filtering out reads
with uncalled bases or length 35 b, 271 million reads were
used for assembly (Supplemental Table S1).
Nuclear, mitochondrial, and Wolbachia genome assemblies
The short-read data were assembled using ABySS 1.2.3 (14). A
number of test assemblies were performed using other assem-
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blers, and a range of parameters was tested within ABySS, and
the final, optimal assembly was performed using a k-mer
length of 35 and scaffolding with the paired-end data only.
Assembly qualities were assessed using summary statistics
including maximizing the N50 (the contig length at which
50% of the assembly span was in contigs of that length or
greater), maximum contig length, and total number of bases
in contigs (see Supplemental Table S1) and using biological
optimality assessment, such as maximizing the coverage of
published D. immitis expressed sequence tag (EST) sequences
and maximizing the number of B. malayi genes matched and
the completeness of representation of core eukaryotic genes
(using CEGMA; ref. 15). Redundancy due to allelic polymor-
phism was reduced with CD-HIT-EST (16), merging contigs
that were 97% identical over the full length of the shorter
contig. The mitochondrial genome was assembled by map-
ping the reads to the published D. immitis mitochondrial
genome (17) and predicting a consensus sequence of the
mitochondrial genomes of the Athens and Pavia nematodes
separately. The wDi genome was assembled by first identifying
likely wDi contigs in the whole assembly with BLASTn (18)
using all Wolbachia genomes from EMBL-Bank, and then
collecting all raw reads (and their pairs; n6,912,659) that
mapped to these putative wDi genome fragments. The re-
duced set of likely wDi reads was then assembled using an
independently optimized ABySS parameter set, using mate-
pair information where available. Mitochondrial and wDi
contigs were removed from the full assembly to leave the final
nuclear assembly.
Transcriptome shotgun sequencing (RNA-Seq) assembly
The preparation of amplicon libraries and RNA-Seq analysis
were performed following standard Illumina TruSeq proto-
cols. A total of 11,019,886 (male) and 21,643,293 (female)
read pairs of length 54 b were produced on the Illumina
GAIIx platform (ArrayExpress accession number E-MTAB-
714; ENA study accession number ERP000758). After quality
filtering, the remaining 31,396,183 pairs were assembled with
Trans-ABySS using k-mer values from 23 to 47 in steps of 4
(Supplemental Table S1).
D. immitis nuclear genome protein-coding gene prediction
and analysis
Repeats in the D. immitis genomic assembly were identified
and masked using RepeatMasker 3.2.9 (19), including all
“Nematoda” repeats in the RepBase libraries (20). The
MAKER 2.08 annotation pipeline (21) was used to identify
protein-coding genes based on evidence from the RNA-Seq
assembly, alignments to the B. malayi proteome (WormBase
release WS220; http://wormbase.sanger.ac.uk/), predictions
made by the ab initio gene finder SNAP (22), and predictions
from the ab initio gene finder Augustus (23) based on the
Augustus hidden Markov model (HMM) profiles for B. ma-
layi. MAKER predicted 11,895 gene models, and, with alter-
native splicing, a total of 12,872 transcripts and peptides. We
compared the nuclear proteome of D. immitis with those of
four other species for which complete genome data are
available and which span the phylogenetic diversity of the
phylum Nematoda (B. malayi, Ascaris suum, Caenorhabditis
elegans, and Trichinella spiralis). The complete proteomes were
compared using all-against-all BLAST, and then clustered
using OrthoMCL (24). OrthoMCL clusters were postpro-
cessed to classify clusters by their species content and ana-
lyzed with reference to the robust molecular phylogeny of the
Nematoda (25). The prediction of D. immitis orthologs from
B. malayi, C. elegans, Homo sapiens, and Canis lupus to identify
drug targets was performed with InParanoid (26).
Analyses of orthology and divergence in filarial Wolbachia
The wDi genome was annotated with the RAST server (27),
an online resource that uses best-practice algorithms to
perform both gene finding and gene functional annotation.
Selected metabolic pathways were annotated based on en-
zyme lists from the KEGG Pathway database (28), after an
HMM profile was generated for each enzyme (29) from a
ClustalW (30) multiple alignment of a redundancy-reduced
set of all the manually curated entries in UniProt (31).
Analysis of orthology was performed using the BLAST recip-
rocal best-hits algorithm (32), with the following cutoff val-
ues: E value 0.1 and ID percentage 60%. Protein distance for
each pair of orthologs was calculated using Protdist in Phylip
3.69 (33) with the Dayhoff PAM matrix option. Proteins were
allocated to functional categories using BLAST against the
COG database. Protein distances were then analyzed based on
COG categories: within each category we calculated the
average distances of protein pairs. To evaluate whether some
categories were significantly more variable than others, we
performed the Kruskal-Wallis test on COG categories contain-
ing more than one ortholog pair. The pairwise Mann-Whitney
test was then performed to detect pairs of COG categories
that displayed significant differences in their average varia-
tion.
Identification of Wolbachia insertions in nematode
genomes
To identify potential lateral genetic transfers from Wolba-
chia to the host nuclear genome, the nuclear genome was
queried against the 921-kbp wDi genome using the dc-
megablast option in BLASTN (NCBI-blast2.2.25) with
default settings. All high-scoring pairs (HSPs) longer than
100 bp with 80% identity were kept. Overlapping HSP
coordinates on the nuclear genome were merged, and
sequences from these coordinates were extracted to obtain
putative nuclear Wolbachia DNA elements. The B. malayi
nuclear genome was screened with the B. malayi Wolbachia
(wBm) genome in the same way. The small numbers of
Wolbachia insertions identified in the nuclear genomes of
Acanthocheilonema viteae and Onchocerca flexuosa (34) were
surveyed for matches to the wDi and wBm genomes and
cross-compared with the insertion sets from the complete
D. immitis and B. malayi genomes using reciprocal best
BLAST searches and filtering alignments shorter than 100
bp. Reciprocal best BLAST matches were isolated and
single-linkage clustered.
RESULTS
Genome assembly of D. immitis and its Wolbachia
symbiont
Genome sequence was generated from single individu-
als of D. immitis isolated from naturally infected dogs,
one from Athens, Georgia (USA) and the other from
Pavia (Italy). A total of 16 Gb of raw data was retained
after rigorous quality checks, corresponding to 170-
fold coverage of the D. immitis nuclear genome (likely
to be 95 Mb, similar to related Onchocercidae). The
ABySS (35) assembler performed best based on statis-
tical and biological measures (Supplemental Table S1).
The mitochondrial and Wolbachia wDi genomes were
assembled independently. The final nuclear assembly
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contained 84.2 Mb of sequence in 31,291 scaffolds with
an N50 of 10,584 bases (Table 1). The draft genome of
wDi consists of 2 scaffolds spanning 0.92 Mb. We
identified 99% of previously deposited genome survey
sequences putatively from wDi (GenBank accession
numbers ET041559 to ET041665) within our wDi as-
sembly. The wDi genome was 16% smaller than that of
wBm (1.08 Mb; GenBank accession number NC_006833),
and there was significant breakage of synteny between
the two genomes, as has been observed between other
Wolbachia.
The D. immitis and wDi genomes, the annotations we
have made on these, and additional technical details
and analyses are available through a dedicated genome
browser (http://www.dirofilaria.org).
Lack of genetic diversity between the sequenced D.
immitis isolates
Even though the two sequenced D. immitis came from
independent isolates from different continents, they
showed low genetic differentiation, allowing the raw
sequencing data from both nematodes to be coas-
sembled. We mapped the reads from each nematode
back to the draft assembly and identified only 32,729
high-quality single-nucleotide variations, a very low
per-nucleotide diversity rate of 0.04%. We identified
the sequences corresponding to 11 polymorphic
microsatellite loci used previously to analyze the D.
immitis population structure in North America (36)
and genotyped our two isolates in silico by counting
the predicted numbers of microsatellite repeats at
each locus. Both our nematodes could be classified
within the diversity of the eastern United States
population. The mitochondrial genomes of the two
isolates differed at only 6 sites (and were thus
99.9% identical). Surprisingly, compared with the
published, Australian D. immitis mitochondrion (17),
both had many shared differences (each was only
99.5% identical to the published D. immitis mitochon-
drion). Because the 70 differences were often
clumped and were unique in the published D. immitis
mitochondrial genome compared both with our two
genomes and with the genomes of five other filarial
nematodes, we suggest that many of these are se-
quencing errors in the published genome.
A metazoan genome without active transposable
elements
The D. immitis genome was surveyed for the three main
classes of transposable elements [DNA transposons,
long terminal repeat (LTR) retrotransposons, and non-
LTR retrotransposons] with tBLASTn (18) using the
transposon-encoded proteins as queries. No traces of
active or pseudogenized DNA transposons or non-LTR
retrotransposons were found, but 376 fragments of
LTR retrotransposons of the BEL/Pao family (37) were
identified. None of these fragments were predicted to
be functional, because all contained frame shifts and
stop codons in the likely coding sequence. The D.
immitis Pao pseudogenes were most similar to Pao
family retrotransposons from B. malayi (6). In B. malayi,
several of the Pao retrotransposons are likely to be
active, because they have complete open reading
frames and LTRs. Overall, however, B. malayi has a
lower density of Pao elements and fragments (3.4
Pao/Mb, 8.3% of which are predicted to be function-
ally intact) compared with D. immitis (4.6 Pao/Mb,
none of which were intact).
D. immitis nuclear proteome
Protein coding genes were predicted in the nuclear
assembly using the MAKER pipeline (21), integrating
evidence-based (RNA-Seq and known protein map-
ping) and ab initio methods. Of the 11,375 gene
models, 897 were predicted to generate alternate
transcripts (Table 1). The total number of predicted
proteins of length 100 aa was 10,179, similar to the
9807 predicted in B. malayi. Based on matches to D.
immitis ESTs and core eukaryotic genes (15), the D.
immitis proteome was likely to be near-complete.
Protein-coding exons occupy 18% of the genome
of D. immitis and 14% of the genome of B. malayi
(Table 1), but in C. elegans there are nearly twice as
many genes, and exons cover 30% of the genome.
The median global identity between a D. immitis
protein and its best match (as determined by
BLASTp) in B. malayi was 75%.
D. immitis proteins were clustered with the com-
plete proteomes of four other nematode species.
These clusters were classified and mapped onto the
phylogenetic tree of the five species based on the
placement of the deepest node that linked the spe-
cies that contributed members (Fig. 1). The D.
immitis proteome included 3199 proteins (31% of the
total proteome) that were unique to this species, a
proportion similar to that found in B. malayi (27%),
but many fewer (and a lower proportion) compared
with those for the other species (for example, C.
elegans had 63% of its proteome in species-unique
TABLE 1. Comparison of the genome assemblies of D. immitis,
B. malayi, and C. elegans
Characteristic D. immitis B. malayi C. elegans
Assembly size (Mb) 84.2 93.6a 100.3
Protein-coding gene models 11,375 11,434 20,517
Genes per megabase 135 122 205
Predicted proteins 12,344 11,460 31,249
Protein-coding sequence (%) 18.0 13.8 25.4
Median exons per gene 5 5 6
Median exon size (b) 142 139 147
Median intron size (b) 226 213 73
Overall GC content (%) 28.3 30.2 35.4
Exon GC content (%) 37.4 39.4 43.4
Intron GC content (%) 26.6 27.2 32.5
B. malayi data are from the GenBank RefSeq dataset; C. elegans
data from the WS230 dataset. a70.8 Mb scaffolds  17.5 Mb short
contigs.
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clusters). This difference may be partly due to the
850 proteins in clusters uniquely shared by the
relatively closely related D. immitis and B. malayi, but
these clusters only raise the proportion of proteins in
phylogenetically local clusters to 47%.
D. immitis genes homologous to known antinematode
drug targets
An array of drugs are effective against nematode parasites
(Table 2). Of these, flubendazole (38), mebendazole
A Dirofilaria immitis protein classification
Dirofilaria immitis only
Onchocercidae
Spiruria
Rhabditia
Nematoda (all)
other patterns
B Cluster origins mapped onto nematode phylogeny
Node a
A+B+C+D+T (3042) A+C+T (233)
A+B+C+T (192) A+B+D+T (128)
A+C+D+T (126) A+T (64)
B+C+D+T (61) C+T (50)
B+D+T (22) D+T (21)
B+T (18) A+D+T (16)
A+B+T (15) C+D+T (9)
B+C+T (6)
Node b
A+B+C+D (1933)
A+C (995)
A+C+D (226)
A+B+C (217)
B+C+D (115)
B+C (50)
C+D (26)
Node c
A+B+D (775)
A+D (196)
A+B (193)
Node d
B+D (850)
Node a
Node b
Node c
Node d
Trichinella spiralis (T)
10,950 species-unique
Ascaris suum (A)
8,995 species-unique
Dirofilaria immitis (D)
3,199 species-unique
Brugia malayi (B)
2,679 species-unique
Caenorhabditis elegans (C)
12,917 species-unique
1062
3941
2304
890
948
3199Figure 1. Conserved and novel genes in D.
immitis. The D. immitis proteome was clustered
with those of B. malayi, A. suum, C. elegans, and
T. spiralis. Clusters were then classified based
on the membership from the five species ac-
cording to the current phylogeny of the phy-
lum Nematoda. A) Pie chart showing the distri-
bution of classification of D. immitis proteins: D.
immitis only, singletons and clusters only found
in D. immitis; Onchocercidae, clusters with
members only from D. immitis and B. malayi;
Spiruria, clusters with members only from On-
chocercidae and A. suum; Rhabditia clusters
with members only from Spiruria and C. elegans;
Nematoda, clusters with members from all five
species (i.e., Rhabditia and T. spiralis); and
other patterns, clusters with members not fit-
ting simply into the phylogenetic schema
(probably arising from gene loss, lack of pre-
dictions, or failure to cluster in one or more
species). B) Cluster numbers and patterns of
conservation mapped onto the phylogeny of
the five species.
TABLE 2. Candidate drug targets, top-down search: current anthelmintics and their known targets in C. elegans and orthologs in D.
immitis
Chemical class Drug Target C. elegans D. immitis
Benzimidazole Albendazole -Tubulin BEN-1 DIMM36740
Flubendazole
Mebendazole
Imidazothiazole Levamisole nACh receptor LEV-1
LEV-8
UNC-29 DIMM30000
UNC-38 DIMM45965
UNC-63 DIMM08405
Macrocyclic lactone Ivermectin Glutamate receptor AVR-14 DIMM16610
Milbemycin AVR-15
Moxidectin GLC-1
Selamectin GLC-2 DIMM25280, DIMM21120
GLC-3
GLC-4 DIMM22030
GABA receptor EXP-1 DIMM57890
GAB-1
UNC-49 DIMM33210
Cyclodepsipeptide Emodepside K channel SLO-1 DIMM33710
Latrophilin GPCR LAT-1 DIMM37270, DIMM37275
LAT-2 DIMM17690
Aminoacetonitrile derivative Monepantel nACh receptor ACR-23
DES-2
nAChR, nicotinic acetylcholine; GPCR, G protein-coupled receptor.
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(39), levamisole (40), ivermectin, milbemycin, moxidec-
tin, and selamectin (41, 42) have been demonstrated to
be active against D. immitis. Many drug targets have been
identified, particularly through forward genetics in the
model nematode C. elegans (43) (Table 2). Prominent
among these targets are neuronal membrane proteins,
highlighting the importance of the neuromuscular junc-
tion as a hotspot of anthelmintic drug action. D. immitis
appears to lack some known targets, notably members of
the DEG-3 subfamily of acetylcholine receptors, which
contains the presumed targets of monepantel (44). This
contrasts with B. malayi, which possesses orthologs of DEG-3
and DES-2 (45). In C. elegans, the target space of
levamisole and ivermectin comprises a large number of
ligand-gated ion channels. Although these drugs are
effective against heartworm, some of these ion channels
do not have an ortholog in D. immitis (Table 2),
indicating that those present are sufficient to confer
drug susceptibility. The identified D. immitis orthologs
of the known anthelmintic targets can now be moni-
tored in suspected cases of drug resistance.
New drug target candidates in D. immitis
New potential drug targets were identified in silico
through an exclusion-inclusion strategy (46, 47). Start-
ing from the complete set of predicted D. immitis
proteins, we excluded proteins that had an ortholog in
the dog or human proteome or had multiple paralogs
in D. immitis. We included proteins that had a C. elegans
ortholog essential for survival or development (based
on RNAi phenotypes) and had predicted function as an
enzyme or receptor. Among the 20 candidates identi-
fied (Table 3) were several proven drug targets, such as
RNA-dependent RNA polymerase (antiviral), apurinic/
apyrimidinic endonuclease and hedgehog proteins (an-
ticancer; ref. 48), UDP-galactopyranose mutase (against
mycobacteria, ref. 49; and kinetoplastids, ref. 50), ste-
rol-C24-methyltransferase (antifungal; ref. 51), and the
insecticide target chitin synthase (52). The D. immitis
orthologs of these enzymes may serve as starting points
for the development of new anthelmintics.
Immune modulators and vaccine candidates
Filarial nematodes modulate the immune systems of
their mammalian hosts to promote their own survival
and fecundity, but the exact mechanisms used remain
enigmatic. Proteases such as leucyl aminopeptidase and
protease inhibitors such as serpins and cystatins have
been implicated in disruption of immune signal pro-
cessing (53), and we identified D. immitis leucyl amino-
TABLE 3. Candidate drug targets, bottom-up search
D. immitis protein Predicted function B. malayi ortholog
H. sapiens
log10 (E)
C. lupus
log10 (E) C. elegans RNAi
Nucleic acid synthesis
and repair
DIMM09370 RNA-dependent RNA polymerase BM06623 0.28 0.11 Lethal
DIMM23395 Apurinic/apyrimidinic endonuclease BM17151 1 0.12 Lethal
Glycosylation and
sugar
metabolism
DIMM15580 dTDP-4-dehydrorhamnose
3,5-epimerase
BM18305 0.23 0.04 Lethal
DIMM03355 -1,4-Mannosyltransferase BM20353 0.95 0.94 Lethal
DIMM44525 UDP-galactopyranose mutase BM01820 0.36 0.08 Molt defective
DIMM36945 Chitin synthase BM18745, BM02779 3.52 4.00 Lethal
Lipid metabolism
DIMM52545 Lipase BM01258, BM03783 0.08 1.60 Lethal
DIMM13730 Sterol-C24-methyltransferase (Erg11) BM20515 3.10 4.00 Lethal
DIMM28375 Methyltransferase BM18889 0.03 0.15 Lethal
Transport
DIMM21065 Aquaporin BM04673 2.05 0.52 Lethal
Signal transduction
DIMM13570 Nuclear hormone receptor 2.40 4.52 Lethal
DIMM11130 G protein-coupled receptor BM19106 1.06 0.59 Lethal
DIMM32415 G protein-coupled receptor 1.26 1.57 Lethal
DIMM39455 G protein-coupled receptor 2.70 1.96 Lethal
DIMM13630 Groundhog protein 1 0.04 Lethal
DIMM47150 Warthog protein BM01098 1 0.78 Lethal
DIMM03220 Warthog protein BM01043, BM17326,
BM08657
1 0.32 Lethal
DIMM11410 Haloacid dehalogenase-like
hydrolase
BM19541 3.22 4.00 Lethal
DIMM13420 Apoptosis regulator CED-9 BM01838 0.77 1.02 Lethal
Potential drug targets were filtered from the predicted D. immitis proteome using the following criteria: 1) presence of an ortholog in C.
elegans that has as an RNAi phenotype lethal, L3_arrest, or molt_defective; 2) absence of a significant BLAST match (E105) in the predicted
proteomes of H. sapiens and C. lupus familiaris; and 3) predicted function as an enzyme or receptor.
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peptidase, as well as 3 cystatins, and many serpins
(Table 4). Another route to modulation is through
recruitment of nematode homologs of ancient system
molecules that have been redeployed in the mamma-
lian immune system, such as TGF- and macrophage
migration inhibition factor (MIF). In D. immitis, we
identified 2 MIF genes, orthologs of the MIF-1 and
MIF-2 genes of B. malayi and O. volvulus and 4 TGF-
homologs (Table 4). Another proposed route to mod-
ulation is by mimicry of immune system signals. We
identified a homolog of suppressor of cytokine signal-
ing 5 (SOCS5), a negative regulator of the JAK/STAT
pathway and inhibitor of the IL-4 pathway in T-helper
cells, promoting TH1 differentiation (54). Several vi-
ruses induce host SOCS protein expression for immune
evasion and survival (55). Interestingly, SOCS5 ho-
mologs were also identified in the animal-parasitic
nematodes B. malayi, D. immitis, Loa loa, A. suum, and T.
spiralis, but were absent from the free-living C. elegans,
the necromenic Pristionchus pacificus, and the plant
parasitic Meloidogyne spp. D. immitis and other filarial
nematodes (56) may use SOCS5 homologs to mimic
host SOCS5. We also identified a homolog of IL-16, a
PDZ domain-containing, pleiotropic cytokine (57). In
mammals, IL-16 acts via the CD4 receptor to modulate
the activity of a wide range of immune effector cells,
including T cells and dendritic cells (58). Again, this
molecule was only present in parasitic nematodes (in-
cluding A. suum; ref. 59) and was absent from genomes
of free-living and plant parasitic species. We suggest
that these molecules and perhaps other mimics of
cytokines and modulators belong to the effector toolkit
used by filarial nematodes to build an immunologically
compromised niche.
We surveyed the D. immitis genome for molecules
currently proposed as vaccine candidates in other on-
chocercids (60, 61) and identified homologs for all 14
classes of molecules (Table 4).
Analysis of the wDi genome: the D. immitis-Wolbachia
symbiosis
wDi genes were predicted using the RAST online
server. We performed an orthology analysis comparing
wBm and wDi and found 538 shared proteins. There
were 259 (with 8 duplicated) and 329 (with 4 dupli-
cated) unique genes, respectively, for wBm and wDi.
COG analysis showed that the total number of genes in
each COG category was similar in the two organisms.
Analysis of pairwise protein distances between wDi and
wBm in different COG categories indicated that there
was significant variation (Kruskal-Wallis P0.00077)
and pairwise Mann-Whitney tests identified 2 of the 14
high-level COG categories as having elevated diver-
gence between the two Wolbachia. The COG categories
showing elevated divergence were M (cell wall, mem-
TABLE 4. D. immitis potential immune modulators and orthologs of onchocercid vaccine candidates
D. immitis protein B. malayi ortholog Description Potential
DIMM39040, DIMM39045 BM18548 Pi-class glutathione S-transferase (GSTP) VC
DIMM29150 BM02625 Tropomyosin (TMY) VC
DIMM29270 BM00759, BM19824 Fatty acid and retinoic acid binding protein (FAR) VC
DIMM47055 BM03010 Fructose bisphosphate aldolase (FBA) VC
DIMM59360 Astacin metalloprotease MP1 VC
DIMM37935, DIMM46475 BM01859, BM09541,
BM14520
Chitinase (CHI) VC
DIMM48695 BM21967, BM08119 Abundant larval transcript 1 (ALT); unknown function
(also known as SLAP)
VC
DIMM48700 BM20051 “RAL-2,” unknown function; DUF148 superfamily (also
known as SXP-1)
VC
DIMM62215, DIMM45570,
DIMM58880
BM03177, BM05783,
BM16294
Activation associated proteins [ASP, also known as venom
allergen homologs (VAH)]
VC
DIMM58690 BM02480 “OV103” Onchocerca vaccine candidate of unknown function VC
DIMM12355 BM07484, BM22082 “B8” Onchocerca vaccine candidate of unknown function VC
DIMM55190, DIMM50565,
DIMM48395
BM00175, BM14240,
BM04930,
BM07956
“B20” Onchocerca vaccine candidate of unknown function VC
DIMM56580 BM05118 Cysteine proteinase inhibitor 2 (CPI-2) VC/IM
DIMM18905 BM04900 Cysteine proteinase inhibitor 3 (CPI-3) VC/IM
DIMM11425 BM21284 Interleukin-16-like (IL16) IM
DIMM57180 BM00325 Leucyl aminopeptidase (LAP) IM
DIMM28945 BM06847 Suppressor of cytokine signaling 5 (SOCS5) IM
DIMM42430 BM07480 Macrophage migration inhibitory factor (MIF-1) IM
DIMM40455 BM16561 Macrophage migration inhibitory factor 2 (MIF-2) IM
DIMM23225 BM17713 Transforming growth factor  (TGF) homolog of C. elegans
TIG-2
IM
DIMM37585 BM20852 TGF homologue of C. elegans DAF-7 IM
DIMM29335 BM21753 TGF homologue of C. elegans DBL-1/CET-1 IM
DIMM61250 BM18112 TGF homologue of C. elegans UNC-129 IM
B. malayi orthologs are referred to by their designation in WormBase WS230. IM, immune modulator; VC, vaccine candidate.
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brane, and envelope biogenesis) and S (function un-
known).
The relationship between filarial nematodes and
their Wolbachia endosymbionts is thought to be a mu-
tualistic symbiosis (62), because extended treatment of
infected mammals with tetracycline and other antibiot-
ics results in clearance of the nematodes. The bases of
this symbiosis remain unclear. It has been proposed
that wBm provides B. malayi with additional sources of
critical metabolites such as heme and riboflavin (63).
We interrogated the wDi genome to examine the
symbiont’s biochemical capabilities. C. elegans and
other nematodes (including B. malayi, and, on the basis
of the genome sequence presented here, D. immitis) are
deficient in heme synthesis but wBm has an intact heme
pathway (Fig. 2) and a CcmB heme exporter, suggest-
ing that it may support its host by providing heme. wBm
has a complete pathway from succinyl-CoA to heme
(one apparently missing component, HemG, may be
substituted by a functional HemY). wDi lacks both
HemY and HemG (and the recently described HemJ
that can perform the same transformation). This step
in the heme pathway is apparently absent in other
bacteria, and so this may not indicate a nonfunctional
heme synthesis pathway. Further anabolic pathways
absent in D. immitis but present in wDi are purine and
pyrimidine de novo synthesis (Fig. 2).
wBm is deficient in folate synthesis because it lacks
dihydrofolate reductase and dihydroneopterin aldo-
lase. wDi has both these genes, suggesting that it can
use dihydroneopterin as an input to folate metabolism.
Wolbachia wMel from Drosophila melanogaster has both
these enzymes, and they are variably present in other
alphaproteobacteria. Whether this pathway contributes
to the nematode symbiosis is unclear, but it does
highlight another component of Wolbachia metabolism
that may be accessible to drug development. Further
wDi gene products that might be exploited as drug
targets include nucleic acid synthesis and cell division
proteins, such as FtsZ and DnaB, the fatty acid synthesis
enzymes FabZ and AcpS, components of the Sec pro-
tein secretion system, and, possibly, the peptidoglycan
synthesis enzymes of the Mur operon. All these are
unique proteins in wDi, do not have counterparts in
mammals, and are being developed as antibiotic drug
targets for bacterial infections (64–68).
Horizontal gene transfer from Wolbachia to host
nuclear genomes is common in animals harboring this
endosymbiont (63), and it has been proposed that
these transfers may confer new functionality to the
nuclear genome (34, 69, 70), although this is unlikely
(71). We identified 868 elements, spanning 219 kb, of
100 b with 80% identity to wDi. The Wolbachia
origin of these elements was supported by clustering
based on the frequency distribution patterns (Supple-
mental Fig. S1) of tetramer palindromes (72). We did
not identify the putative complex Wolbachia insertion
discussed by Dunning-Hotopp et al. (70) involving the
antigen Dg2 gene. We found a version of the Dg2 gene
in our predicted transcriptome that contained standard
nematode introns, but no evidence of the construct
previously described that had the introns of Dg2 largely
replaced with sequences that match 100% to the wDi
genome. It is likely that this sequence is a laboratory or
computational artifact, especially because the construct
includes a cloning vector sequence in addition to
Wolbachia.
Only 9 of our identified elements matched 80% of
the length of a wDi open reading frame and were not
interrupted by frame-shifting insertions or deletions or
stop codons. Only one of these putative lateral gene
transfers had a match to a Wolbachia protein of known
function (transcription termination factor, NusB). We
found no evidence of transcription of this gene in the
male and female RNA-Seq data. We applied the same
procedure for finding Wolbachia insertions to the B.
malayi genome and identified 654 insertions spanning
327 kb. Only 31 pairs of insertions that were probably
derived from homologous Wolbachia genes were found
(in both of the two genomes). None of these shared
insertions had complete open reading frames. Compar-
ison with the Wolbachia insertions in the partial ge-
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Figure 2. Anabolic pathways in Wolbachia and Dirofilaria. Se-
lected pathways were identified by screening the predicted
proteomes with HMM profiles representing each enzyme in the
pathway using HMMer (29). The proteomes were hierarchically
clustered (77) based on city block distance between the vectors
consisting of the best scores (represented as a heat plot)
obtained against each profile. A complete prediction of D.
immitis metabolic pathways is available online at the Draft
Genomes page of the Kyoto Encyclopedia of Genes and Ge-
nomes (http://www.genome.jp/kegg/catalog/org_list1.html).
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nomes of A. viteae and O. flexuosa, onchocercid nema-
todes that have lost their symbionts (34), revealed no
insertions shared by all four species. Only 48 insertions
were shared by 2 species and 5 were shared by 3. The
number of shared fragments was as would be expected
from homoplasious, random insertion of Wolbachia
fragments independently into their host genomes. If
25% of the genome was randomly transferred in all
species, the number of shared fragments expected by
chance would be 45 (0.250.25750 fragments). We
thus tentatively conclude that, although elements from
wDi have transferred to the nuclear genome, there is
no evidence of their functional integration into nema-
tode biology.
DISCUSSION
The D. immitis genome sequence described here is only
the second to be determined for an onchocercid nem-
atode, despite the social and economic importance of
these parasites. Three genomes were cosequenced: the
mitochondrial (at 4000-fold read coverage of the
13.6-kb genome; this had been determined previously;
ref. 17); the genome of the Wolbachia symbiont wDi (at
1000-fold coverage of the 0.9-Mb genome); and the
nuclear genome (at 150-fold coverage of the esti-
mated 95-Mb genome). We used high-throughput,
short-read Illumina technology, stringent quality filter-
ing and optimized assembly methods to derive ge-
nomes of good draft quality (73). After redundancy
reduction, the span of the nuclear assembly was 84.2
Mb, slightly smaller than the 88.3 Mb assembled for B.
malayi (6). Overall, although the number of scaffolds
was approximately equivalent, the contiguity of the D.
immitis genome assembly was lower than that of B.
malayi, because of the availability of long-range scaffold-
ing information for the latter species. The predicted
nuclear gene set was much smaller than that of C.
elegans, but of a size similar to that of B. malayi. The two
onchocercid nematodes also have a lower proportion
of species-unique proteins. These two differences may
be a feature of the Onchocercidae, because the unpub-
lished L. loa genome has only 15,444 predicted proteins
(Filarial Worms Sequencing Project, Broad Institute of
Harvard and MIT; http://www.broadinstitute.org/).
Another possibility is that the richer analytic environ-
ment for C. elegans in particular has permitted the
identification of many unique genes using biological
evidence (such as transcript information). We will
continue to develop and improve the assembly and
annotation of D. immitis and wDi as additional tools and
biological resources become available.
Two peculiarities of the assembled D. immitis genome
are striking: the lack of genetic diversity and the lack of
active transposable elements. The lack of diversity was
convenient, in that it allowed us to pool data obtained
from two different D. immitis isolates, one from Pavia,
Italy, and the other from Athens, Georgia, USA. Poly-
morphisms called from the independent sequencing of
the two isolates yielded a per-nucleotide diversity of
0.04%. Both sequenced isolates fall within the single
eastern United States population defined by microsat-
ellite analyses (36). The hypovariability may be a result
of the recent admixture of European and American
heartworm populations through movement of domes-
tic animals or arise from the very recent introduction of
heartworm into the New World by Europeans (74). The
first report of dirofilariasis in the United States dates
from only 1847, as opposed to a 1626 observation from
Italy. The lack of genetic diversity in the nuclear
genome will make identification of mutations confer-
ring drug resistance much easier. The lack of DNA
transposons and active retrotransposons in D. immitis is
a strong negative result, because active elements are
easy to identify (they are present in multiple, highly
similar copies). We identified only fragmented and
functionally inactivated segments of Pao-type retro-
transposons, similar to those found in and probably still
active in B. malayi. To our knowledge, this is the first
metazoan genome devoid of active transposable ele-
ments. The presence of putatively active Pao elements
in B. malayi suggests that their loss was an evolutionary
recent event in D. immitis.
The Wolbachia wDi genome, with 823 predicted pro-
teins, complements the D. immitis nuclear genome in
that it encodes enzymes for anabolic pathways that are
missing in the latter, e.g., biosynthesis of heme, purine,
or pyrimidines (Fig. 2). In contrast to wBm, wDi also
carries the genes for folate synthesis, suggesting that
folate too might be supplied by the endosymbiont.
However, essential metabolites could also be taken up
from the mammalian or insect host, and so it remains
to be shown whether such metabolites are actually
delivered from wDi to D. immitis. Analysis of orthology
between wBm and wDi revealed that both organisms
possess many unique genes (approximately one-third of
the total gene complement of each genome). The
representation of genes in the different COG catego-
ries was similar for wBm and wDi, suggesting that most
gene losses occurred before the split of the two lineages
or that there have been no biases in gene losses/
acquisition after the evolutionary separation. Analysis
of protein distances revealed that proteins involved in
cell wall/membrane biogenesis (COG category M)
displayed more variation between the two organisms
compared with the other functional categories. It is
reasonable to conclude that the interface between the
symbiotic bacterium and the host environment is a
place where evolutionary rates are elevated, either as
part of an arms race underpinning conflict between the
two genomes or as a feature of the dynamic exploita-
tion of the interface in adaptation of the symbiosis. In
any case, the endosymbiont, being essential for prolif-
eration of D. immitis, represents a target for control of
the heartworm. Screening the predicted wDi proteome
returned expected antibiotic drug targets such as Fts
and Sec proteins, but also the products of the Mur
operon required for peptidoglycan synthesis.
Many of the anthelmintics used in human medicine
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were originally developed for the veterinary sector. We
pursued two approaches to identify potential drug
targets in D. immitis: top-down, starting from the known
anthelmintic targets of C. elegans (Table 2), and bot-
tom-up, narrowing down the predicted D. immitis pro-
teome to a list of essential, unique, and druggable
targets (Table 3). Although the majority of the current
anthelmintics activate their target (thereby interfering
with synaptic signal transduction), the aim of the
second approach was to identify inhibitable targets.
The criteria applied—presence of an essential ortholog
in C. elegans, absence of any significantly similar protein
in human or dog, and absence of paralogs in D.
immitis—admittedly missed many of the known anthel-
mintic targets, e.g., proteins that are not conserved in C.
elegans or that possess a mammalian ortholog. The aim
of the approach was to maximize the specificity of in
silico target prediction at the cost of low sensitivity. Our
goal was to end up with a manageable, rather than
complete, list of unique D. immitis proteins that are
likely to be essential and druggable. Some of the
candidates identified are worth further investigation,
based on their presumed role in signal transduction,
e.g., the nematode-specific G protein-coupled receptors
or hedgehog proteins (Table 3). Others have already
been validated as drug targets in other systems: sterol-
C-24-methyltransferase (EC 2.1.1.41) is a target of sine-
fungin, chitin synthase (EC 2.4.1.16) is the target of the
insecticide lufenuron, and the mannosyltransferase
bre-3 is required for interaction of Bacillus thuringiensis
toxin with intestinal cells (52). The discovery of new D.
immitis drug targets would be timely because resistance
to macrocyclic lactones has recently been reported
from the southern United States (75).
Filarial nematodes modulate the immune systems of
their hosts in complex ways that result in an apparently
intact immune system that ignores a large parasite
residing, sometimes for decades, in tissues or the
bloodstream. They may also require intact immune
systems to develop properly (76). Often immune re-
sponses result in a pathologic condition for the host in
addition to parasite clearance, and Wolbachia may exac-
erbate these responses (12). We identified a wide range
of putative immunomodulatory molecules and, in ad-
dition, highlight two D. immitis products that may
deflect or distract the host immune response: one
similar to SOCS5 and the other similar to IL-18. The
host-encoded versions of both of these molecules have
been implicated in antifilarial immune responses. Strat-
egies for development of a vaccine against filariases
depend on delivering the correct antigens to the right
arm of the immune system, avoiding induction of
dangerous responses, and deflecting or stopping im-
mune suppression by the parasite. We identified ho-
mologs of all the current roster of filarial vaccine
candidates in our genome, and these can now be
moved rapidly into testing in the dog heartworm
model. In addition, we defined a large number of
potentially secreted D. immitis proteins that may con-
tribute to the host-parasite interaction and also be
accessible to the host immune system.
Onchocercid parasites share not only a fascinating
biology involving immune evasion, arthropod vectors,
and Wolbachia endosymbionts but also a pressing need
for new drugs, improved diagnostic methods, and,
ideally, vaccines. We hope that the genome sequence of
the heartworm presented here will contribute to an
increased understanding of its biology and to new leads
for control.
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